Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca plc    AZN   GB0009895292

Delayed Quote. Delayed  - 02/11 11:35:09 am
3991 GBp   -0.45%
07:10a ASTRAZENECA : 11 February 2016 AstraZeneca and MedImmune enter conso..
02/09 ASTRAZENECA : Fight against hypertension spreads in Eastern Africa
02/08 ASTRAZENECA : Gets European Approval for Its New Lung Cancer Drug
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

UK Health Watchdog Backs Lung Cancer Drug From Roche

05/09/2012 | 07:16pm US/Eastern

The U.K.'s health-care watchdog said in final draft guidance Thursday that it is recommending the use of Roche Holding AG's (ROG.VX) Tarceva as a treatment option for advanced-stage lung-cancer patients.

The National Institute for Health and Clinical Excellence, known as NICE, decides what medicines should be used in the U.K.'s publicly-funded National Health Service. It said the drug--whose chemical name is erlotinib--is a cost-effective use of NHS resources.

NICE, which has already recommended AstraZeneca PLC's (>> AstraZeneca plc) Iressa, or gefitinib, for non-small-cell lung cancer, said that while there isn't any trial data directly comparing the two drugs, clinical specialists say the drugs are "very similar and equally as effective."

"We are pleased to be able to recommend another treatment option for this stage of the disease," said NICE Director Carole Longson.

The watchdog said its decision to back the drug came after it requested more information about it from the Swiss drug maker.

Roche wasn't immediately available for comment.

NICE said the draft guidance is now with consultees, who have the opportunity to appeal against it.

-By Marta Falconi, Dow Jones Newswires; +41 43 443 8043; marta.falconi@dowjones.com

Stocks mentioned in the article : AstraZeneca plc, AstraZeneca plc
React to this article
Latest news on ASTRAZENECA PLC
07:10a ASTRAZENECA : 11 February 2016 AstraZeneca and MedImmune enter consortium to del..
02/09 ASTRAZENECA : Fight against hypertension spreads in Eastern Africa
02/08 ASTRAZENECA : Gets European Approval for Its New Lung Cancer Drug
02/08 ASTRAZENECA : Pro-Poor Health Initiative Expands Across Africa
02/08 ASTRAZENECA PLC : Looking Into the Price Movements - Consensus Reports on Astraz..
02/08 ASTRAZENECA : TAGRISSO (osimertinib) approved in EU as first-in-class treatment ..
02/08 ASTRAZENECA : *hsbc cuts astrazeneca to 'hold' ('buy') - price target 4880 pence
02/08 ASTRAZENECA : Intarcia Appoints Dr. John Yee into New Role of VP, Global Medical..
02/07DJSuper Bowl TV Ads Bring Lighter Tone--
02/05 SANOFI : Zealand clarifies its role in US patent litigation relating to lixisena..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials